DMOAD may also not be possible due to the differences in dosing required (2mg/kg for pain and function and 1mg/kg for DMOAD). So are we hoping against hope that 1.5 mg/kg provides the best of both worlds? It's equally possible it may provide neither.
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-237
-
- There are more pages in this discussion • 150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.015(4.84%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 29.0¢ | $120.1K | 390.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9796 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 9952 | 5 |
View Market Depth
| Last trade - 13.44pm 15/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |